RESUMEN
Multiparameter flow cytometry data is visually inspected by expert personnel as part of standard clinical disease diagnosis practice. This is a demanding and costly process, and recent research has demonstrated that it is possible to utilize artificial intelligence (AI) algorithms to assist in the interpretive process. Here we report our examination of three previously published machine learning methods for classification of flow cytometry data and apply these to a B-cell neoplasm dataset to obtain predicted disease subtypes. Each of the examined methods classifies samples according to specific disease categories using ungated flow cytometry data. We compare and contrast the three algorithms with respect to their architectures, and we report the multiclass classification accuracies and relative required computation times. Despite different architectures, two of the methods, flowCat and EnsembleCNN, had similarly good accuracies with relatively fast computational times. We note a speed advantage for EnsembleCNN, particularly in the case of addition of training data and retraining of the classifier.
Asunto(s)
Algoritmos , Citometría de Flujo , Aprendizaje Automático , Humanos , Citometría de Flujo/métodos , Linfoma de Células B/clasificación , Linfoma de Células B/diagnóstico , Linfoma de Células B/patología , Linfocitos B/patología , Linfocitos B/clasificación , Linfocitos B/inmunología , Inmunofenotipificación/métodosRESUMEN
The therapeutic efficacy of B-cell depletion by anti-CD20 treatment in pediatric and, more recently, in adult idiopathic nephrotic syndrome patients suggests a key role of B cells in the pathogenesis of the disease. However, their exact role is still unclear. B cells are able to secrete a large variety of antibodies that can protect against infections. However, B-cell dysregulation is well-established in a variety of autoimmune diseases. In parallel with their ability to produce antibodies, pathogenic B cells display altered effector functions by expressing activating surface molecules, which can strongly modify the immune homeostasis, or by producing specific cytokines, which can directly affect either podocyte structure and functions or modulate T-cell homeostasis. Herein, we report the most relevant clinical and experimental evidences of a pathogenic role of B cells in idiopathic nephrotic syndrome. We further highlight similarities and differences between children and adults affected by non-genetic forms of the disease and discuss what needs to be investigated in order to define the exact mechanisms underlying the pathogenic role of B cells and to identify more tailored therapeutic approaches.
Asunto(s)
Linfocitos B/patología , Glomeruloesclerosis Focal y Segmentaria/patología , Nefrosis Lipoidea/patología , Síndrome Nefrótico/patología , Adulto , Anticuerpos/inmunología , Linfocitos B/clasificación , Linfocitos B/inmunología , Niño , Citocinas/inmunología , Glomeruloesclerosis Focal y Segmentaria/inmunología , Humanos , Nefrosis Lipoidea/inmunología , Síndrome Nefrótico/inmunología , Fenotipo , Podocitos/patologíaRESUMEN
Upon infection with Mycobacterium tuberculosis (Mtb) the host immune response might clear the bacteria, control its growth leading to latent tuberculosis (LTB), or fail to control its growth resulting in active TB (ATB). There is however no clear understanding of the features underlying a more or less effective response. Mtb glycolipids are abundant in the bacterial cell envelope and modulate the immune response to Mtb, but the patterns of response to glycolipids are still underexplored. To identify the CD45+ leukocyte activation landscape induced by Mtb glycolipids in peripheral blood of ATB and LTB, we performed a detailed assessment of the immune response of PBMCs to the Mtb glycolipids lipoarabinomannan (LAM) and its biosynthetic precursor phosphatidyl-inositol mannoside (PIM), and purified-protein derivate (PPD). At 24 h of stimulation, cell profiling and secretome analysis was done using mass cytometry and high-multiplex immunoassay. PIM induced a diverse cytokine response, mainly affecting antigen-presenting cells to produce both pro-inflammatory and anti-inflammatory cytokines, but not IFN-γ, contrasting with PPD that was a strong inducer of IFN-γ. The effect of PIM on the antigen-presenting cells was partly TLR2-dependent. Expansion of monocyte subsets in response to PIM or LAM was reduced primarily in LTB as compared to healthy controls, suggesting a hyporesponsive/tolerance pattern derived from Mtb infection.
Asunto(s)
Tuberculosis Latente/inmunología , Tuberculosis/inmunología , Adulto , Anciano , Anciano de 80 o más Años , Antígenos Bacterianos/administración & dosificación , Antígenos Bacterianos/inmunología , Linfocitos B/clasificación , Linfocitos B/inmunología , Estudios de Casos y Controles , Estudios de Cohortes , Citocinas/biosíntesis , Femenino , Glucolípidos/administración & dosificación , Glucolípidos/inmunología , Humanos , Técnicas In Vitro , Células Asesinas Naturales/inmunología , Masculino , Persona de Mediana Edad , Mycobacterium tuberculosis/inmunología , Células Mieloides/inmunología , Fosfatidilinositoles/administración & dosificación , Fosfatidilinositoles/inmunología , Estudios Prospectivos , Linfocitos T/clasificación , Linfocitos T/inmunología , Receptor Toll-Like 2/inmunología , Tuberculina/administración & dosificación , Tuberculina/inmunología , Adulto JovenRESUMEN
B lymphocytes ('B cells') are components of the human immune system with obvious potential for medical and biotechnological applications. Here, we discuss the isolation of primary human B cells from both juvenile and adult tonsillar material using a two-step procedure based on gradient centrifugation followed by separation on a nylon wool column as alternative to the current gold standard, i.e., negative immunosorting from buffy coats by antibody-coated magnetic beads. We show that the nylon wool separation is a low-cost method well suited to the isolation of large amounts of primary B cells reaching purities ≥ 80%. More importantly, this method allows the preservation of all B cell subsets, while MACS sorting seems to be biased against a certain B cell subtype, namely the CD27+ B cells. Importantly, compared to blood, the excellent recovery yield during purification of tonsillar B cells provides high number of cells, hence increases the number of subsequent experiments feasible with identical cell material, consequently improving comparability of results. The cultivability of the isolated B cells was demonstrated using pokeweed mitogen (PWM) as a stimulatory substance. Our results showed for the first time that the proliferative response of tonsillar B cells to mitogens declines with the age of the donor. Furthermore, we observed that PWM treatment stimulates the proliferation of a dedicated subpopulation and induces some terminal differentiation with ASCs signatures. Taken together this indicates that the proposed isolation procedure preserves the proliferative capability as well as the differentiation capacity of the B cells.
Asunto(s)
Linfocitos B/citología , Separación Celular/métodos , Tonsila Palatina/citología , Adulto , Linfocitos B/clasificación , Linfocitos B/efectos de los fármacos , Técnicas de Cultivo de Célula , Proliferación Celular/efectos de los fármacos , Separación Celular/normas , Células Cultivadas , Centrifugación , Niño , Humanos , Nylons , Mitógenos de Phytolacca americana/farmacologíaRESUMEN
Despite the advent of effective, curative treatments for hepatitis C virus (HCV), a preventative vaccine remains essential for the global elimination of HCV. It is now clear that the induction of broadly neutralising antibodies (bNAbs) is essential for the rational design of such a vaccine. This review details the current understanding of epitopes on the HCV envelope, characterising the potency, breadth and immunodominance of antibodies induced against these epitopes, as well as describing the interactions between B-cell receptors and HCV infection, with a particular focus on bNAb heavy and light chain variable gene usage. Additionally, we consider the importance of a public repertoire for antibodies against HCV, compiling current knowledge and suggesting that further research in this area may be critical to the rational design of an effective HCV vaccine.
Asunto(s)
Linfocitos B/inmunología , Hepacivirus/inmunología , Epítopos Inmunodominantes/inmunología , Anticuerpos Monoclonales/inmunología , Anticuerpos Neutralizantes/inmunología , Linfocitos B/clasificación , Anticuerpos ampliamente neutralizantes/inmunología , Mapeo Epitopo , Hepacivirus/genética , Hepatitis C/virología , Anticuerpos contra la Hepatitis C/inmunología , Humanos , Vacunas contra Hepatitis Viral/inmunologíaRESUMEN
BACKGROUND: Traditional laboratory model organisms represent a small fraction of the diversity of multicellular life, and findings in any given experimental model often do not translate to other species. Immunology research in non-traditional model organisms can be advantageous or even necessary, such as when studying host-pathogen interactions. However, such research presents multiple challenges, many stemming from an incomplete understanding of potentially species-specific immune cell types, frequencies, and phenotypes. Identifying and characterizing immune cells in such organisms is frequently limited by the availability of species-reactive immunophenotyping reagents for flow cytometry, and insufficient prior knowledge of cell type-defining markers. RESULTS: Here, we demonstrate the utility of single-cell RNA sequencing (scRNA-Seq) to characterize immune cells for which traditional experimental tools are limited. Specifically, we used scRNA-Seq to comprehensively define the cellular diversity of equine peripheral blood mononuclear cells (PBMC) from healthy horses across different breeds, ages, and sexes. We identified 30 cell type clusters partitioned into five major populations: monocytes/dendritic cells, B cells, CD3+PRF1+ lymphocytes, CD3+PRF1- lymphocytes, and basophils. Comparative analyses revealed many cell populations analogous to human PBMC, including transcriptionally heterogeneous monocytes and distinct dendritic cell subsets (cDC1, cDC2, plasmacytoid DC). Remarkably, we found that a majority of the equine peripheral B cell compartment is comprised of T-bet+ B cells, an immune cell subpopulation typically associated with chronic infection and inflammation in human and mouse. CONCLUSIONS: Taken together, our results demonstrate the potential of scRNA-Seq for cellular analyses in non-traditional model organisms and form the basis for an immune cell atlas of horse peripheral blood.
Asunto(s)
Caballos/sangre , Leucocitos Mononucleares/clasificación , Animales , Linfocitos B/clasificación , Leucocitos Mononucleares/metabolismo , Análisis de Secuencia de ARN/veterinaria , Análisis de la Célula Individual/veterinariaRESUMEN
BACKGROUND AIMS: Adoptive cellular therapy with immune effector cells (IECs) has shown promising efficacy against some neoplastic diseases as well as potential in immune regulation. Both inherent variability in starting material and variations in cell composition produced by the manufacturing process must be thoroughly evaluated with a validated method established to quantify viable lymphocyte subtypes. Currently, commercialized immunophenotyping methods determine cell viability with significant errors in thawed products since they do not include any viability staining. We hereby report on the validation of a flow cytometry-based method for quantifying viable lymphocyte immunophenotypes in fresh and cryopreserved hematopoietic cellular products. METHODS: Using fresh or frozen cellular products and stabilized blood, we report on the validation parameters accuracy, uncertainty, precision, sensitivity, robustness and contamination between samples for quantification of viable CD3+, CD4+ T cells, CD8+ T cells, CD3-CD56+CD16+/- NK cells, CD19+ B cells and CD14+ monocytes of relevance to fresh and cryopreserved hematopoietic cellular products using the Cytomics FC500 cytometer (Beckman Coulter). RESULTS: The acceptance criteria set in the validation plan were all met. The method is able to accommodate the variability in absolute numbers of cells in starting materials collected or cryopreserved from patients or healthy donors (uncertainty of ≤20% at three different concentrations), stability over time (compliance over 3 years during regular inter-laboratory comparisons) and confidence in meaningful changes during cell processing and manufacturing (intra-assay and intermediate precision of 10% coefficient of variation). Furthermore, the method can accurately report on the efficacy of cell depletion since the lower limit of quantification was established (CD3+, CD4+ and CD8+ cells at 9, 8 and 8 cells/µL, respectively). The method complies with Foundation for the Accreditation of Cellular Therapy (FACT) standards for IEC, FACT-Joint Accreditation Committee of ISCT-EBMT (JACIE) hematopoietic cell therapy standards, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Q2(R1) and International Organization for Standardization 15189 standards. Furthermore, it complies with Ligand Binding Assay Bioanalytical Focus Group/American Association of Pharmaceutical Scientists, International Council for Standardization of Hematology/International Clinical Cytometry Society and European Bioanalysis Forum recommendations for validating such methods. CONCLUSIONS: The implications of this effort include standardization of viable cell immunophenotyping of starting material for cell manufacturing, cell selection and in-process quality controls or dosing of IECs. This method also complies with all relevant standards, particularly FACT-JACIE standards, in terms of enumerating and reporting on the viability of the "clinically relevant cell populations."
Asunto(s)
Linfocitos B/clasificación , Criopreservación , Citometría de Flujo/métodos , Citometría de Flujo/normas , Subgrupos de Linfocitos T/clasificación , Adulto , Linfocitos B/metabolismo , Humanos , Inmunofenotipificación , Masculino , Reproducibilidad de los ResultadosRESUMEN
Human immune systems are very complex, and the basis for individual differences in immune phenotypes is largely unclear. One reason is that the phenotype of the immune system is so complex that it is very difficult to describe its features and quantify differences between samples. To identify the genetic factors that cause individual differences in whole lymphocyte profiles and their changes after vaccination without having to rely on biological assumptions, we performed a genome-wide association study (GWAS), using cytometry data. Here, we applied computational analysis to the cytometry data of 301 people before receiving an influenza vaccine, and 1, 7, and 90 days after the vaccination to extract the feature statistics of the lymphocyte profiles in a nonparametric and data-driven manner. We analyzed two types of cytometry data: measurements of six markers for B cell classification and seven markers for T cell classification. The coordinate values calculated by this method can be treated as feature statistics of the lymphocyte profile. Next, we examined the genetic basis of individual differences in human immune phenotypes with a GWAS for the feature statistics, and we newly identified seven significant and 36 suggestive single-nucleotide polymorphisms associated with the individual differences in lymphocyte profiles and their change after vaccination. This study provides a new workflow for performing combined analyses of cytometry data and other types of genomics data.
Asunto(s)
Estudio de Asociación del Genoma Completo , Sistema Inmunológico/virología , Gripe Humana/sangre , Linfocitos/inmunología , Linfocitos B/clasificación , Linfocitos B/inmunología , Linfocitos B/ultraestructura , Linfocitos B/virología , Minería de Datos , Femenino , Citometría de Flujo , Humanos , Sistema Inmunológico/ultraestructura , Vacunas contra la Influenza/efectos adversos , Gripe Humana/inmunología , Gripe Humana/prevención & control , Linfocitos/ultraestructura , Linfocitos/virología , Masculino , Polimorfismo de Nucleótido Simple/genética , Linfocitos T/clasificación , Linfocitos T/inmunología , Linfocitos T/ultraestructura , Linfocitos T/virología , Vacunación/efectos adversosRESUMEN
The use of flow cytometry allows simultaneous measurement and multiparametric analysis of single cells in a heterogenous solution. The purpose of flow cytometry can vary depending on the use of antibodies and dyes targeted for specific cell molecules. The method of immune-phenotyping with fluorescently conjugated antibodies to label cell proteins or DNA works in tandem with fluidic, optic, and electrical systems present in the flow cytometer. Some flow cytometers can detect numerous fluorescent molecules on a single cell, allowing the measurement of more than 30 parameters. This ability to detect, measure, and quantitate multiple fluorescent markers on a single cell makes the flow cytometer a useful tool for analyzing various aspects of cell phenotype and function. Here we describe a standardized protocol for surface and intracellular immune-phenotyping of murine lungs, beginning with the building of an optimal antibody panel and ending with data analysis and representation, including sample gating strategies for innate and adaptive immune responses.
Asunto(s)
Citometría de Flujo/métodos , Colorantes Fluorescentes/química , Inmunofenotipificación/métodos , Pulmón/metabolismo , Coloración y Etiquetado/métodos , Inmunidad Adaptativa , Animales , Anticuerpos/química , Antígenos CD/genética , Antígenos CD/inmunología , Linfocitos B/clasificación , Linfocitos B/citología , Linfocitos B/metabolismo , Biomarcadores/análisis , Carbocianinas/química , Recuento de Células , Supervivencia Celular , Células Dendríticas/citología , Células Dendríticas/metabolismo , Eosinófilos/citología , Eosinófilos/metabolismo , Citometría de Flujo/instrumentación , Humanos , Inmunidad Innata , Pulmón/citología , Macrófagos Alveolares/citología , Macrófagos Alveolares/metabolismo , Ratones , Monocitos/citología , Monocitos/metabolismo , Neutrófilos/citología , Neutrófilos/metabolismo , Cultivo Primario de Células , Linfocitos T/clasificación , Linfocitos T/citología , Linfocitos T/metabolismoRESUMEN
A recombinant fowl adenovirus (FAdV) fiber protein, derived from a FAdV-8a strain, was tested for its efficacy to protect chickens against inclusion body hepatitis (IBH). FAdV-E field isolates belonging to both a homotypic (FAdV-8a) and heterotypic (-8b) serotype were used as challenge. Mechanisms underlying fiber-induced protective immunity were investigated by fiber-based ELISA, virus neutralization assays and flow cytometry of peripheral blood mononuclear cells, monitoring the temporal developments of humoral and cellular responses after vaccination and challenge exposure. Birds were clinically protected from the homologous challenge and showed a significant reduction of viral load in investigated target organs, whereas fiber-based immunity failed to counteract the heterologous serotype infection. These findings were supported in vitro by the strictly type-specific neutralizing activity of fiber immune sera. In protected birds, fiber vaccination prevented a post-challenge drop of peripheral B cells in blood. Furthermore, fiber immunization stimulated CD4+ T lymphocyte proliferation while moderating the CD8α+ T cell response and prevented challenge-induced changes in systemic monocytes/macrophages and γδ+ T cell subpopulations. Both vaccinated and adjuvant-only injected birds experienced a priming of systemic B cells and TCRγδ+ T lymphocytes, which masked possible pre-challenge effects due to the antigen. In conclusion, within FAdV-E, recombinant fiber represents a vaccine candidate to control the adverse effects of homotypic infection by eliciting an effective humoral immunity and regulating B and T cell response, whereas the failure of heterotypic protection suggests a primordial role of humoral immunity for this vaccine.
Asunto(s)
Pollos , Adenovirus A Aviar/metabolismo , Hepatitis Viral Animal/prevención & control , Inmunidad Celular/inmunología , Vacunas contra Hepatitis Viral/inmunología , Proteínas Virales/inmunología , Animales , Linfocitos B/clasificación , Linfocitos B/metabolismo , Enfermedades de las Aves de Corral/prevención & control , Enfermedades de las Aves de Corral/virología , Organismos Libres de Patógenos Específicos , Linfocitos T/clasificación , Linfocitos T/metabolismoRESUMEN
The proactive generation of anti-idiotypic antibodies (anti-IDs) against therapeutic antibodies with desirable properties is an important step in pre-clinical and clinical assay development supporting their bioanalytical programs. Here, we describe a robust platform to generate anti-IDs using rabbit single B cell sorting-culture and cloning technology by immunizing rabbits with therapeutic drug Fab fragment and sorting complementarity determining regions (CDRs) specific B cells using designed framework control as a negative gate to exclude non-CDRs-specific B cells. The supernatants of cultured B cells were subsequently screened for binding to drug-molecule by enzyme-linked immunosorbent assay and the positive hits of B cell lysates were selected for cloning of their immunoglobulin G (IgG) variable regions. The recombinant monoclonal anti-IDs generated with this method have high affinity and specificity with broad epitope coverage and different types. The recombinant anti-IDs were available for assay development to support pharmacokinetic (PK) and immunogenicity studies within 12 weeks from the start of rabbit immunization. Using this novel rapid and efficient in-house approach we have generated a large panel of anti-IDs against a series of 11 therapeutic antibody drugs and successfully applied them to the clinical assay development.
Asunto(s)
Anticuerpos Antiidiotipos/inmunología , Anticuerpos Monoclonales/inmunología , Afinidad de Anticuerpos , Linfocitos B/inmunología , Separación Celular/métodos , Epítopos/inmunología , Animales , Anticuerpos Antiidiotipos/genética , Anticuerpos Monoclonales/genética , Linfocitos B/clasificación , Células Cultivadas , Clonación Molecular/métodos , Epítopos/genética , Humanos , Región Variable de Inmunoglobulina/genética , Región Variable de Inmunoglobulina/inmunología , ConejosRESUMEN
Memory B cells (MBCs) are long-lived and produce high-affinity, generally, class-switched antibodies. Here, we use a multiparameter approach involving CD27 to segregate naïve B cells (NBC), IgD+ unswitched (unsw)MBCs and IgG+ or IgA+ class-switched (sw)MBCs from humans of different age, sex and race. Conserved antibody variable gene expression indicates that MBCs emerge through unbiased selection from NBCs. Integrative analyses of mRNAs, miRNAs, lncRNAs, chromatin accessibility and cis-regulatory elements uncover a core mRNA-ncRNA transcriptional signature shared by IgG+ and IgA+ swMBCs and distinct from NBCs, while unswMBCs display a transitional transcriptome. Some swMBC transcriptional signature loci are accessible but not expressed in NBCs. Profiling miRNAs reveals downregulated MIR181, and concomitantly upregulated MIR181 target genes such as RASSF6, TOX, TRERF1, TRPV3 and RORα, in swMBCs. Finally, lncRNAs differentially expressed in swMBCs cluster proximal to the IgH chain locus on chromosome 14. Our findings thus provide new insights into MBC transcriptional programs and epigenetic regulation, opening new investigative avenues on these critical cell elements in human health and disease.
Asunto(s)
Linfocitos B/inmunología , Memoria Inmunológica/genética , Adulto , Linfocitos B/clasificación , Linfocitos B/metabolismo , Cromatina/genética , Cromatina/inmunología , Regiones Determinantes de Complementariedad , Epigénesis Genética , Femenino , Perfilación de la Expresión Génica , Humanos , Cambio de Clase de Inmunoglobulina/genética , Cadenas Pesadas de Inmunoglobulina/genética , Masculino , MicroARNs/genética , MicroARNs/metabolismo , Mutación Puntual , Transducción de Señal/genética , Factores de Transcripción/genética , Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/metabolismo , Adulto JovenRESUMEN
The global Coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has affected more than eight million people. There is an urgent need to investigate how the adaptive immunity is established in COVID-19 patients. In this study, we profiled adaptive immune cells of PBMCs from recovered COVID-19 patients with varying disease severity using single-cell RNA and TCR/BCR V(D)J sequencing. The sequencing data revealed SARS-CoV-2-specific shuffling of adaptive immune repertories and COVID-19-induced remodeling of peripheral lymphocytes. Characterization of variations in the peripheral T and B cells from the COVID-19 patients revealed a positive correlation of humoral immune response and T-cell immune memory with disease severity. Sequencing and functional data revealed SARS-CoV-2-specific T-cell immune memory in the convalescent COVID-19 patients. Furthermore, we also identified novel antigens that are responsive in the convalescent patients. Altogether, our study reveals adaptive immune repertories underlying pathogenesis and recovery in severe versus mild COVID-19 patients, providing valuable information for potential vaccine and therapeutic development against SARS-CoV-2 infection.
Asunto(s)
Linfocitos B/inmunología , Betacoronavirus/patogenicidad , Infecciones por Coronavirus/inmunología , Inmunidad Celular , Inmunidad Humoral , Neumonía Viral/inmunología , Linfocitos T/inmunología , Antígenos Virales/genética , Antígenos Virales/inmunología , Linfocitos B/clasificación , Linfocitos B/virología , Betacoronavirus/inmunología , COVID-19 , Estudios de Casos y Controles , China , Convalecencia , Infecciones por Coronavirus/genética , Infecciones por Coronavirus/patología , Infecciones por Coronavirus/virología , Progresión de la Enfermedad , Expresión Génica , Secuenciación de Nucleótidos de Alto Rendimiento , Interacciones Huésped-Patógeno/inmunología , Humanos , Memoria Inmunológica , Pandemias , Neumonía Viral/genética , Neumonía Viral/patología , Neumonía Viral/virología , Receptores de Antígenos de Linfocitos B/clasificación , Receptores de Antígenos de Linfocitos B/genética , Receptores de Antígenos de Linfocitos B/inmunología , Receptores de Antígenos de Linfocitos T/clasificación , Receptores de Antígenos de Linfocitos T/genética , Receptores de Antígenos de Linfocitos T/inmunología , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Análisis de la Célula Individual , Linfocitos T/clasificación , Linfocitos T/virologíaRESUMEN
Malaria caused by Plasmodium vivax is a highly prevalent infection world-wide, that was previously considered mild, but complications such as anemia have been highly reported in the past years. In mice models of malaria, anti-phosphatidylserine (anti-PS) autoantibodies, produced by atypical B-cells, bind to uninfected erythrocytes and contribute to anemia. In human patients with P. falciparum malaria, the levels of anti-PS, atypical B-cells and anemia are strongly correlated to each other. In this study, we focused on assessing the relationship between autoantibodies, different B-cell populations and hemoglobin levels in two different cohorts of P. vivax patients from Colombia, South America. In a first longitudinal cohort, our results show a strong inverse correlation between different IgG autoantibodies tested (anti-PS, anti-DNA and anti-erythrocyte) and atypical memory B-cells (atMBCs) with hemoglobin in both P. vivax and P. falciparum patients over time. In a second cross-sectional cohort, we observed a stronger relation between hemoglobin levels, atMBCs and autoantibodies in complicated P. vivax patients compared to uncomplicated ones. Altogether, these data constitute the first evidence of autoimmunity associating with anemia and complicated P. vivax infections, suggesting a role for its etiology through the expansion of autoantibody-secreting atMBCs.
Asunto(s)
Anemia/complicaciones , Autoanticuerpos/sangre , Linfocitos B/clasificación , Malaria Vivax/sangre , Malaria Vivax/complicaciones , Anemia/sangre , Anemia/inmunología , Hemoglobinas/metabolismo , Humanos , Malaria Falciparum/sangre , Malaria Falciparum/complicaciones , Malaria Falciparum/inmunología , Fosfatidilserinas/inmunología , Plasmodium falciparum , Plasmodium vivaxRESUMEN
The increasingly recognized role of different types of B cells and plasma cells in protective and pathogenic immune responses combined with technological advances have generated a plethora of information regarding the heterogeneity of this human immune compartment. Unfortunately, the lack of a consistent classification of human B cells also creates significant imprecision on the adjudication of different phenotypes to well-defined populations. Additional confusion in the field stems from: the use of non-discriminatory, overlapping markers to define some populations, the extrapolation of mouse concepts to humans, and the assignation of functional significance to populations often defined by insufficient surface markers. In this review, we shall discuss the current understanding of human B cell heterogeneity and define major parental populations and associated subsets while discussing their functional significance. We shall also identify current challenges and opportunities. It stands to reason that a unified approach will not only permit comparison of separate studies but also improve our ability to define deviations from normative values and to create a clean framework for the identification, functional significance, and disease association with new populations.
Asunto(s)
Linfocitos B Reguladores/inmunología , Linfocitos B/inmunología , Memoria Inmunológica/inmunología , Células Plasmáticas/inmunología , Animales , Linfocitos B/clasificación , Linfocitos B Reguladores/metabolismo , Citocinas/inmunología , Citocinas/metabolismo , Humanos , Inmunidad Humoral/inmunología , Inmunoglobulina D/inmunología , Inmunoglobulina D/metabolismo , Inmunoglobulina M/inmunología , Inmunoglobulina M/metabolismo , Células Plasmáticas/clasificaciónRESUMEN
The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets.
Asunto(s)
Linfocitos B/inmunología , Linaje de la Célula/genética , Células Dendríticas/inmunología , ARN Mensajero/genética , Linfocitos T/inmunología , Transcriptoma , Adulto , Linfocitos B/clasificación , Linfocitos B/citología , Basófilos/clasificación , Basófilos/citología , Basófilos/inmunología , Benchmarking , Linaje de la Célula/inmunología , Células Dendríticas/clasificación , Células Dendríticas/citología , Femenino , Citometría de Flujo , Voluntarios Sanos , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Inmunofenotipificación , Células Asesinas Naturales/clasificación , Células Asesinas Naturales/citología , Células Asesinas Naturales/inmunología , Masculino , Monocitos/clasificación , Monocitos/citología , Monocitos/inmunología , Neutrófilos/clasificación , Neutrófilos/citología , Neutrófilos/inmunología , Especificidad de Órganos , ARN Mensajero/inmunología , Células Madre/clasificación , Células Madre/citología , Células Madre/inmunología , Linfocitos T/clasificación , Linfocitos T/citologíaRESUMEN
A Dengue é uma doença viral sistêmica, transmitida por mosquitos, que afeta anualmente cerca de 100 milhões de pessoas em todo o mundo. Causada por quatro sorotipos do vírus da Dengue (DENV), suas manifestações clínicas podem variar de assintomáticas à formas que podem levar a óbito. Curiosamente, os pacientes com Dengue apresentam uma resposta exacerbada das células secretoras de anticorpos (ASCs) no sangue cerca de sete dias após o início dos sintomas. A frequência dessas ASCs induzidas pelo DENV representa mais de 50% de todas as células B circulantes no sangue. Essa quantificação é maior que aquelas encontradas em outras infecções virais, contextos de imunização e até mesmo em pacientes com neoplasias de ASCs. Além disso, a magnitude dessa resposta transitória se correlaciona com a gravidade da doença. Então, como a infecção pelo DENV induz essa resposta enorme? Para responder à essa pergunta, combinamos abordagens in vitro e in silico. Células mononucleares do sangue periférico (PBMCs) obtidas de indivíduos saudáveis foram cultivadas in vitro durante sete dias na presença do DENV ou mitógenos. Após a estimulação pelo DENV, as células B presentes nas PBMCs foram capazes de se diferenciarem em ASCs, tanto fenotipicamente quanto funcionalmente, em magnitude similar àquelas estimuladas com mitógenos. Essa diferenciação demonstrou ser dependente da presença de outras células contidas nas PBMCs, assim como do contato célula-célula. Embora ambos os estímulos tenham sido capazes de induzir a diferenciação de ASCs, eles diferiram metabolicamente e transcricionalmente. PBMCs estimuladas pelo DENV apresentaram um maior consumo de triptofano, associado à maior expressão de IDO1 e IDO2 e maior síntese de quinurenina, bem como maiores expressões de IL-10, BAFF e SYK. Ainda, as concentrações de quinurenina foram positivamente correlacionadas com a enumeração de ASCs nessas culturas. Dados de transcriptoma públicos de pacientes com Dengue também suportam esses achados. Outros flavivírus, como o vírus Zika e a cepa vacinal da Febre Amarela não foram capazes de induzir a mesma magnitude de diferenciação das células B em ASCs in vitro. Tão pouco apresentaram correlação entre a enumeração de ASCs e a síntese de quinurenina. Por fim, através da construção de uma hipotética via de diferenciação de células B em ASCs durante infecção pelo DENV, através da combinação de dados da literatura e transcriptomas públicos, demonstramos que moléculas relacionadas à via do STAT3 (IL-10, IL-6, IRF4 e BLIMP1) estão mais expressas nos pacientes infectados e moléculas que respondem aos sinais de cálcio (Calcineurina, NFATC1, DOK3 e GRB2) estão menos expressas nos pacientes infectados. Esses dados proporcionam um melhor entendimento da resposta de células B durante a infeção pelo DENV, particularmente sobre como o metabolismo e a sinalização das células B estão conectados nesse processo
Dengue is a mosquito-borne viral disease that affects annually about 100 million people worldwide. Caused by four Dengue virus (DENV) serotypes, it ranges from asymptomatic to life threatening forms. Curiously, Dengue patients present an exacerbated blood antibody-secreting cell (ASCs) response around seven days after the symptoms onset. The frequency of those DENV-induced ASCs represents more than 50% of all circulating blood B cells. This is greater than found in others viral infections, immunization contexts and even in ASCs related-leukemia patients. Moreover, the magnitude of that transitory response correlates with the disease severity. So, how does the DENV infection induce this enormous response? In order to answer this question we have combined in vitro and in silico approaches. Peripheral blood mononuclear cells (PBMC) obtained from healthy individuals were cultured in vitro during seven days in the presence of DENV or mitogens. Upon the DENV stimulation, PBMC-contained B cells were able to differentiate phenotypically and functionally into ASCs, both phenotypically and functionally, in a similar magnitude than mitogen-stimulated cells. This differentiation was demonstrated to be dependent of the presence of the remaining PBMCs, as well as of the cell-cell contact. Although both stimuli were able to induce the ASCs differentiation, they differed metabolically and transcriptionally. DENV-stimulated PBMCs showed higher tryptophan consumption, associated with higher IDO1 and IDO2 expression and higher kynurenine synthesis, as well as higher IL-10, BAFF and SYK expressions compared to mitogen-exposed counterparts. Additionally, the kynurenine concentrations were positively correlated with the ASCs-enumeration in those cultures. Public transcriptome data supports these findings as well. Other flaviviruses, such as Zika virus and the attenuated vaccine Yellow Fever were not able to induce the same magnitude of ASCs differentiation in vitro. Hence, they did not present a correlation between the number of generated ASCs and the supernatant kynurenine levels. Based on the combination of the literature and public transcriptome data, we have constructed a hypothetical B cell differentiation pathway that might be occurring during DENV infection. It displays that STAT3 pathway-related molecules (IL-10, IL-6, IRF4 and BLIMP1) are more expressed in Dengue patients and molecules that respond to calcium signals (Calcineurin, NFATC1, DOK3 and GRB2) are less expressed in Dengue patients than in control. These data provide a better understanding of the B cell response elicited by DENV infection, particularly about how the B cell metabolism and signaling can be connected into this process
Asunto(s)
Triptófano/metabolismo , Virus del Dengue/crecimiento & desarrollo , Metabolismo , Células Productoras de Anticuerpos/inmunología , Técnicas In Vitro/instrumentación , Linfocitos B/clasificación , QuinureninaRESUMEN
The disruption of adaptive immune response has adverse effects on the establishment and maintenance of pregnancy. The adaptive immune system is regulated by several types of immune cells. However, there is limited information about cell hierarchy in the adaptive immune response to the establishment and maintenance of pregnancy in women. The assessment of the outcome of pregnancy in primary immunodeficiency diseases could help in understanding the cell hierarchy in the adaptive immune system during pregnancy. Common variable immunodeficiency (CVID) is a heterogeneous adaptive immune system disorder characterized by primary hypogammaglobulinemia. A few studies have previously reported the assessment of the T and B cell subpopulations in CVID patients. However, an assessment of the subpopulations of T and B cells and the outcome of pregnancy in women with CVID has not been reported till date. Most CVID patients show a general decrease in the expression of CD27 in B cells. The assessment of pregnancy and the subpopulations of T and B cells in CVID women with severe reduction in the naïve T and switched B cells could help understand whether these cells are essential for the establishment and maintenance of pregnancy in women.
Asunto(s)
Linfocitos B/inmunología , Inmunodeficiencia Variable Común/inmunología , Cambio de Clase de Inmunoglobulina , Inmunoglobulina D/inmunología , Memoria Inmunológica , Linfocitos T/inmunología , Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral/inmunología , Adulto , Agammaglobulinemia/inmunología , Linfocitos B/clasificación , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Femenino , Sangre Fetal/inmunología , Humanos , Infertilidad Femenina/inmunología , Embarazo , Complicaciones del Embarazo , Resultado del Embarazo , Linfocitos T Reguladores/citologíaRESUMEN
B cells possess various immuno regulatory functions. However, research about their participation in tolerance induction toward the fetus is just emerging. Accumulating evidence supports the idea that B cells can play seemingly conflicting roles during pregnancy, either protecting or harming the fetus. Previous findings indicated the presence of two different peritoneal B cell subsets, defined by the expression of the plasma cell alloantigen 1 (PC1) and with distinct immune modulatory functions. Here, we aimed to study the participation of these two B cell subsets, on pregnancy outcome in a murine model of disturbed fetal tolerance. The frequencies and cell numbers of peritoneal and splenic CD19+IL-10+ and CD19+CD5+IL-10+PC1+ cells were assessed in virgin as well as normal pregnant (NP) and abortion-prone (AP) females during the course of gestation. Peritoneal PC1low or PC1high B1a B cells were sorted, analyzed for their ability to secrete IL-10 and adoptively transferred into NP or AP females. On gestation day (gd) 12, the abortion rate as well as the frequencies and cell numbers of regulatory T cells, TH1 and TH17 cells were determined in spleens and decidua. In addition, mRNA expression of IL-10, TGF-ß, IFN-γ, and TNF-α was analyzed in decidual tissue. Peritoneal CD19+IL-10+ and CD19+CD5+IL-10+PC1+ frequencies fluctuated during the progression of normal pregnancies while no significant changes were observed in spleen. AP females showed significantly reduced frequencies of both B cell populations and exhibited an altered peritoneal PC1high/PC1low ratio at gd10. Adoptive transfers of PC1low B1a B cells into NP females increased the abortion rate in association with a reduced splenic regulatory T/TH17 ratio. By contrast, the transfer of PC1high B1a B cells into AP females significantly diminished the fetal rejection rate and significantly reduced the numbers of splenic TH17 cells. Our results suggest that the peritoneum harbors two distinct B1a B cell subsets that can be distinguished by their PC1 expression. Whereas PC1high B1a B cells seem to support fetal survival, PC1low cells B1a B cells may compromise fetal well-being.
Asunto(s)
Aborto Espontáneo , Antígenos de Diferenciación de Linfocitos B/inmunología , Linfocitos B/inmunología , Feto/inmunología , Interleucina-10/inmunología , Isoantígenos/inmunología , Traslado Adoptivo , Animales , Linfocitos B/clasificación , Linfocitos B Reguladores/inmunología , Citocinas/inmunología , Femenino , Ratones , Ratones Endogámicos BALB C , Embarazo , Bazo/inmunología , Linfocitos T Reguladores/inmunología , Células TH1/inmunología , Células Th17/inmunologíaRESUMEN
BACKGROUND: The success of clinical trials of selective B cell depletion in patients with relapsing multiple sclerosis (MS) indicates B cells are important contributors to peripheral immune responses involved in the development of new relapses. Such B cell contribution to peripheral inflammation likely involves antibody-independent mechanisms. Of growing interest is the potential that B cells, within the MS central nervous system (CNS), may also contribute to the propagation of CNS-compartmentalized inflammation in progressive (non-relapsing) disease. B cells are known to persist in the inflamed MS CNS and are more recently described as concentrated in meningeal immune-cell aggregates, adjacent to the subpial cortical injury which has been associated with progressive disease. How B cells are fostered within the MS CNS and how they may contribute locally to the propagation of CNS-compartmentalized inflammation remain to be elucidated. METHODS: We considered whether activated human astrocytes might contribute to B cell survival and function through soluble factors. B cells from healthy controls (HC) and untreated MS patients were exposed to primary human astrocytes that were either maintained under basal culture conditions (non-activated) or pre-activated with standard inflammatory signals. B cell exposure to astrocytes included direct co-culture, co-culture in transwells, or exposure to astrocyte-conditioned medium. Following the different exposures, B cell survival and expression of T cell co-stimulatory molecules were assessed by flow cytometry, as was the ability of differentially exposed B cells to induce activation of allogeneic T cells. RESULTS: Secreted factors from both non-activated and activated human astrocytes robustly supported human B cell survival. Soluble products of pre-activated astrocytes also induced B cell upregulation of antigen-presenting cell machinery, and these B cells, in turn, were more efficient activators of T cells. Astrocyte-soluble factors could support survival and activation of B cell subsets implicated in MS, including memory B cells from patients with both relapsing and progressive forms of disease. CONCLUSIONS: Our findings point to a potential mechanism whereby activated astrocytes in the inflamed MS CNS not only promote a B cell fostering environment, but also actively support the ability of B cells to contribute to the propagation of CNS-compartmentalized inflammation, now thought to play key roles in progressive disease.